Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 55536

1.

25-HC decreases the sensitivity of human gastric cancer cells to 5-fluorouracil and promotes cells invasion via the TLR2/NF-κB signaling pathway.

Wang S, Yao Y, Rao C, Zheng G, Chen W.

Int J Oncol. 2019 Jan 11. doi: 10.3892/ijo.2019.4684. [Epub ahead of print]

PMID:
30664194
2.

Rational choice of induction chemotherapy-based larynx preservation for hypopharyngeal cancer.

Liu S, Fang J, Ma H, Meng L, Bai Y, Feng L, Lian M, Li P, Zhong Q, Hou L.

Acta Otolaryngol. 2019 Jan 21:1-8. doi: 10.1080/00016489.2018.1506152. [Epub ahead of print]

PMID:
30663475
3.

Repurposing Screen Identifies Unconventional Drugs With Activity Against Multidrug Resistant Acinetobacter baumannii.

Cheng YS, Sun W, Xu M, Shen M, Khraiwesh M, Sciotti RJ, Zheng W.

Front Cell Infect Microbiol. 2019 Jan 4;8:438. doi: 10.3389/fcimb.2018.00438. eCollection 2018.

PMID:
30662875
4.

Galactosylated chitosan-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery.

Liu W, Zhu Y, Wang F, Li X, Liu X, Pang J, Pan W.

R Soc Open Sci. 2018 Dec 5;5(12):181027. doi: 10.1098/rsos.181027. eCollection 2018 Dec.

PMID:
30662725
5.

Additional Chemotherapy with 5-FU plus Leucovorin between Preoperative Chemoradiotherapy and Surgery Improved Treatment Outcomes in Patients with Advanced Rectal Cancer.

Park SE, Choi JH, Choi CH, Park SW, Kim BG, Cha SJ, Hwang IG.

J Cancer. 2019 Jan 1;10(1):186-191. doi: 10.7150/jca.25366. eCollection 2019.

PMID:
30662539
6.

Complete response with fluorouracil and irinotecan with a BRAFV600E and EGFR inhibitor in BRAF-mutated metastatic colorectal cancer: a case report.

Wang Z, Dai WP, Zang YS.

Onco Targets Ther. 2019 Jan 8;12:443-447. doi: 10.2147/OTT.S180845. eCollection 2019.

PMID:
30662270
7.

Oncologic outcomes after adjuvant chemotherapy with capecitabine compared to 5-fluorouracil/leucovorin for geriatric stage II colon cancer: a retrospective cohort study.

Lee KY, Park JW, Lee KY, Cho S, Kwon YH, Kim MJ, Ryoo SB, Jeong SY, Park KJ.

Int J Colorectal Dis. 2019 Jan 19. doi: 10.1007/s00384-019-03237-x. [Epub ahead of print]

PMID:
30661101
8.

Research on 5-fluorouracil as a drug carrier materials with its in vitro release properties on organic modified magadiite.

Ge M, Wei T, Du M, Liang G, Hu G, Jahangir Alam SM.

Eur J Pharm Sci. 2019 Jan 17. pii: S0928-0987(19)30025-9. doi: 10.1016/j.ejps.2019.01.017. [Epub ahead of print]

PMID:
30660800
9.

Real-World Outcomes of Adjuvant Chemotherapy for Node-Negative and Node-Positive HER2-Positive Breast Cancer.

Veitch Z, Khan OF, Tilley D, Ribnikar D, Kostaras X, King K, Tang P, Lupichuk S.

J Natl Compr Canc Netw. 2019 Jan;17(1):47-56. doi: 10.6004/jnccn.2018.7066.

PMID:
30659129
10.

Phase II trial of aflibercept with FOLFIRI as a 2nd-line treatment for Japanese patients with metastatic colorectal cancer.

Denda T, Sakai D, Hamaguchi T, Sugimoto N, Ura T, Yamazaki K, Fujii H, Kajiwara T, Nakajima TE, Takahashi S, Otsu S, Komatsu Y, Nagashima F, Moriwaki T, Esaki T, Sato T, Itabashi M, Oki E, Sasaki T, Sunaga Y, Ziti-Ljajic S, Brillac C, Yoshino T.

Cancer Sci. 2019 Jan 18. doi: 10.1111/cas.13943. [Epub ahead of print]

11.

Systemic Lupus Erythematosus is Not Necessarily a Contraindication to Adjuvant Breast Radiation Therapy.

Martell K, Long K, Solis A, Olivotto IA.

Cureus. 2018 Nov 13;10(11):e3584. doi: 10.7759/cureus.3584.

12.

Enhanced Tumor Selectivity of 5-Fluorouracil Using a Reactive Oxygen Species-Activated Prodrug Approach.

Ai Y, Obianom ON, Kuser M, Li Y, Shu Y, Xue F.

ACS Med Chem Lett. 2018 Dec 3;10(1):127-131. doi: 10.1021/acsmedchemlett.8b00539. eCollection 2019 Jan 10.

PMID:
30655959
13.

Two postoperative chemotherapies for gastric cancer: FOLFOX4 vs. TPF.

Xie H, Lu Q, Wang H, Zhu X, Guan Z.

Oncol Lett. 2019 Jan;17(1):933-936. doi: 10.3892/ol.2018.9695. Epub 2018 Nov 14.

15.

The Phenolic compound Kaempferol overcomes 5-fluorouracil resistance in human resistant LS174 colon cancer cells.

Riahi-Chebbi I, Souid S, Othman H, Haoues M, Karoui H, Morel A, Srairi-Abid N, Essafi M, Essafi-Benkhadir K.

Sci Rep. 2019 Jan 17;9(1):195. doi: 10.1038/s41598-018-36808-z.

16.

Serine Threonine Kinase 17A maintains the epithelial state in colorectal cancer cells.

Short SP, Thompson JJ, Bilotta AJ, Chen X, Revetta FL, Washington MK, Williams CS.

Mol Cancer Res. 2019 Jan 17. pii: molcanres.0990.2018. doi: 10.1158/1541-7786.MCR-18-0990. [Epub ahead of print]

PMID:
30655319
17.

Reply to comments on "comparison of efficacy and safety of intralesional triamcinolone and combination of triamcinolone with 5-fluorouracil in the treatment of keloids and hypertrophic scars: Randomised control trial".

Khalid FA, Mehrose MY, Saleem M, Amin M, Mujahid AM, Rehman SU, AhmAd S, Tarar MN.

Burns. 2019 Jan 14. pii: S0305-4179(18)31110-0. doi: 10.1016/j.burns.2018.12.014. [Epub ahead of print] No abstract available.

PMID:
30655058
18.

Adipocytes promote breast cancer resistance to chemotherapy, a process amplified by obesity: role of the major vault protein (MVP).

Lehuédé C, Li X, Dauvillier S, Vaysse C, Franchet C, Clement E, Esteve D, Longué M, Chaltiel L, Le Gonidec S, Lazar I, Geneste A, Dumontet C, Valet P, Nieto L, Fallone F, Muller C.

Breast Cancer Res. 2019 Jan 17;21(1):7. doi: 10.1186/s13058-018-1088-6.

19.

NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors.

Wang-Gillam A, Hubner RA, Siveke JT, Von Hoff DD, Belanger B, de Jong FA, Mirakhur B, Chen LT.

Eur J Cancer. 2019 Jan 14;108:78-87. doi: 10.1016/j.ejca.2018.12.007. [Epub ahead of print]

PMID:
30654298
20.

Microneedling with dermaroller 192 needles along with 5-fluorouracil solution in the treatment of stable vitiligo.

Kumar A, Bharti R, Agarwal S.

J Am Acad Dermatol. 2019 Jan 14. pii: S0190-9622(19)30084-2. doi: 10.1016/j.jaad.2018.12.066. [Epub ahead of print] No abstract available.

PMID:
30654074

Supplemental Content

Loading ...
Support Center